Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04531150
Recruitment Status : Completed
First Posted : August 28, 2020
Last Update Posted : June 11, 2021
Information provided by (Responsible Party):
Inversago Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 16, 2021
Actual Study Completion Date : May 16, 2021